Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
WD repeat domain 59 (WDR59) is a protein-coding gene and a component of the GATOR2 complex, which regulates the mTORC1 signaling pathway in response to amino acid availability. WDR59 acts as a signaling adaptor, enabling cellular responses to nutrient status and promoting cell growth via mTORC1 activation when amino acids are abundant. Functionally, WDR59 has tissue- and context-dependent roles, either promoting or inhibiting mTORC1 activity by modulating the interaction between the GATOR2 and GATOR1 complexes. Mutations or alterations in WDR59 have been implicated in diseases such as epilepsy and may contribute to tumorigenesis due to its role in mTOR signaling regulation
Activation/inhibition of mTORC1 via modulation of GATOR2/GATOR1 complexes
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on WD repeat domain 59 (WDR59).